Skip to content

CareStart™ Malaria RDT

CareStart™ Malaria RDT
Access Bio
65 Clyde Rd. Suite A Somerset, NJ 08873 USA
+1 732 873 4040
info@accessbio.net
accessbio logo
Solution Overview & Benefits
Nearly half of the world’s population is at risk of malaria infection and malaria is one of the three major infectious diseases in the world. As more malaria parasites are becoming resistant to antimalarial drugs, the WHO recommends prescribing anti-malarials only to diagnosed patients.
Test Type: Qualitative Rapid Diagnostic Test
Specimen Type: Whole Blood/
Specimen Volume: 5μl
Result Time: 20 min.
Storage Condition Varies on Product: 1-40°C or 4-30
History & Development

A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.

Availability
  • Publicly available: yes
  • Countries where available: Worldwide
  • Price range (USD): Contact supplier for quote
  • Available online: yes

Similar solutions...

HealthPulse AI App

Audere
Smartphone-based tool that uses AI to interpret rapid diagnostic tests in low-resource settings.

HERA Digital App

HERA
Mobile health platform that connects refugee populations with existing healthcare worldwide.

MaternaWall Tray

Maternova
Medical device designed to accurately measure postpartum blood loss, aiding in the early detection and management of postpartum hemorrhage.

HealthPulse AI App

Audere
Smartphone-based tool that uses AI to interpret rapid diagnostic tests in low-resource settings.

Get in Touch!

Get in touch with us by filling out the form or emailing us at contact@techxlab.org.